In the present study, we correlated stromal CD10 expression in breast carcinoma and found a strong association of stromal CD10 with negative prognostic factors such as higher tumor grade, ER negativity, and PR-negative status signifying its association with aggressive behavior of the tumor. The gene discussed is ESR1; the disease is breast carcinoma.